Relaxant effects of butylidenephthalide in isolated dog blood vessels

Wun Chang Ko, Chao Chiun Liao, Chih Hsien Shih, Chien Bang Lei, Chi Ming Chen

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We investigated the reason why butylidenephthalide (Bdph) can have an antianginal effect without changing blood pressure in conscious rats. Isolated dog coronary artery (CA), femoral vein (FV), femoral artery (FA), and mesenteric artery (MA) were used to evaluate the relaxant effects of Bdph. Bdph concentration-dependently relaxed isolated CA, FV, FA, and MA precontracted by KCl (60 mM) and phenylephrine (phe, 5 μM) with the exception that CA was precontracted by prostaglandin F2a (PGF2a, 2μM) instead of phe. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph also concentration-dependently and non-competitively inhibited cumulative KCl (5-120 mM)- and phe (0.1 - 100 μM)-induced contractions in normal, and inhibited cumulative Ca2+-induced contractions in depolarized blood vessels. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph (0.02-0.04 mM) concentration-dependently and leftward-shifted the log concentration-response curves in parallel and significantly increased the pD2 value of forskolin, but not nitroprusside in FV. Bdph (0.1 mM) did both in CA. Bdph (0.225-0.45 mM) did the opposite to that of nitroprusside, but not forskolin, in FA. Bdph (0.45-0.9 mM) did neither in MA. Bdph (0.1-1 mM) significantly inhibited cAMP-but not cGMP-PDE activities in these four blood vessels, suggesting that Bdph more selectively inhibited the former in these tissues. The above results suggest that the higher potencies of Bdph on FV and CA than on FA and MA, may be interpreted as the reason why Bdph is useful in the treatment of angina pectoris without changing blood pressure, after Bdph administration in vivo, because the venoreturn may be reduced and the coronary flow may be increased without affecting the arterioles, such as MA, the main determinant of blood pressure.

Original languageEnglish
Pages (from-to)1004-1009
Number of pages6
JournalPlanta Medica
Volume68
Issue number11
DOIs
Publication statusPublished - Nov 1 2002

Fingerprint

Blood vessels
thighs
blood vessels
Blood Vessels
mesenteric arteries
Dogs
coronary vessels
dogs
Mesenteric Arteries
Femoral Artery
Femoral Vein
arteries
Coronary Vessels
blood pressure
Blood pressure
forskolin
butylidenephthalide
Nitroprusside
Colforsin
Blood Pressure

Keywords

  • Butylidenephthalide
  • Ca influx
  • Ca release
  • cAMP-phosphodiesterase
  • cGMP-phosphodiesterase
  • Dog blood vessels
  • Ligusticum chuaxiong
  • Umbelliferae

ASJC Scopus subject areas

  • Plant Science
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Ko, W. C., Liao, C. C., Shih, C. H., Lei, C. B., & Chen, C. M. (2002). Relaxant effects of butylidenephthalide in isolated dog blood vessels. Planta Medica, 68(11), 1004-1009. https://doi.org/10.1055/s-2002-35671

Relaxant effects of butylidenephthalide in isolated dog blood vessels. / Ko, Wun Chang; Liao, Chao Chiun; Shih, Chih Hsien; Lei, Chien Bang; Chen, Chi Ming.

In: Planta Medica, Vol. 68, No. 11, 01.11.2002, p. 1004-1009.

Research output: Contribution to journalArticle

Ko, WC, Liao, CC, Shih, CH, Lei, CB & Chen, CM 2002, 'Relaxant effects of butylidenephthalide in isolated dog blood vessels', Planta Medica, vol. 68, no. 11, pp. 1004-1009. https://doi.org/10.1055/s-2002-35671
Ko, Wun Chang ; Liao, Chao Chiun ; Shih, Chih Hsien ; Lei, Chien Bang ; Chen, Chi Ming. / Relaxant effects of butylidenephthalide in isolated dog blood vessels. In: Planta Medica. 2002 ; Vol. 68, No. 11. pp. 1004-1009.
@article{2bf48bd4ae3b4bceb93854f64d93d0bd,
title = "Relaxant effects of butylidenephthalide in isolated dog blood vessels",
abstract = "We investigated the reason why butylidenephthalide (Bdph) can have an antianginal effect without changing blood pressure in conscious rats. Isolated dog coronary artery (CA), femoral vein (FV), femoral artery (FA), and mesenteric artery (MA) were used to evaluate the relaxant effects of Bdph. Bdph concentration-dependently relaxed isolated CA, FV, FA, and MA precontracted by KCl (60 mM) and phenylephrine (phe, 5 μM) with the exception that CA was precontracted by prostaglandin F2a (PGF2a, 2μM) instead of phe. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph also concentration-dependently and non-competitively inhibited cumulative KCl (5-120 mM)- and phe (0.1 - 100 μM)-induced contractions in normal, and inhibited cumulative Ca2+-induced contractions in depolarized blood vessels. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph (0.02-0.04 mM) concentration-dependently and leftward-shifted the log concentration-response curves in parallel and significantly increased the pD2 value of forskolin, but not nitroprusside in FV. Bdph (0.1 mM) did both in CA. Bdph (0.225-0.45 mM) did the opposite to that of nitroprusside, but not forskolin, in FA. Bdph (0.45-0.9 mM) did neither in MA. Bdph (0.1-1 mM) significantly inhibited cAMP-but not cGMP-PDE activities in these four blood vessels, suggesting that Bdph more selectively inhibited the former in these tissues. The above results suggest that the higher potencies of Bdph on FV and CA than on FA and MA, may be interpreted as the reason why Bdph is useful in the treatment of angina pectoris without changing blood pressure, after Bdph administration in vivo, because the venoreturn may be reduced and the coronary flow may be increased without affecting the arterioles, such as MA, the main determinant of blood pressure.",
keywords = "Butylidenephthalide, Ca influx, Ca release, cAMP-phosphodiesterase, cGMP-phosphodiesterase, Dog blood vessels, Ligusticum chuaxiong, Umbelliferae",
author = "Ko, {Wun Chang} and Liao, {Chao Chiun} and Shih, {Chih Hsien} and Lei, {Chien Bang} and Chen, {Chi Ming}",
year = "2002",
month = "11",
day = "1",
doi = "10.1055/s-2002-35671",
language = "English",
volume = "68",
pages = "1004--1009",
journal = "Planta Medica",
issn = "0032-0943",
publisher = "Georg Thieme Verlag",
number = "11",

}

TY - JOUR

T1 - Relaxant effects of butylidenephthalide in isolated dog blood vessels

AU - Ko, Wun Chang

AU - Liao, Chao Chiun

AU - Shih, Chih Hsien

AU - Lei, Chien Bang

AU - Chen, Chi Ming

PY - 2002/11/1

Y1 - 2002/11/1

N2 - We investigated the reason why butylidenephthalide (Bdph) can have an antianginal effect without changing blood pressure in conscious rats. Isolated dog coronary artery (CA), femoral vein (FV), femoral artery (FA), and mesenteric artery (MA) were used to evaluate the relaxant effects of Bdph. Bdph concentration-dependently relaxed isolated CA, FV, FA, and MA precontracted by KCl (60 mM) and phenylephrine (phe, 5 μM) with the exception that CA was precontracted by prostaglandin F2a (PGF2a, 2μM) instead of phe. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph also concentration-dependently and non-competitively inhibited cumulative KCl (5-120 mM)- and phe (0.1 - 100 μM)-induced contractions in normal, and inhibited cumulative Ca2+-induced contractions in depolarized blood vessels. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph (0.02-0.04 mM) concentration-dependently and leftward-shifted the log concentration-response curves in parallel and significantly increased the pD2 value of forskolin, but not nitroprusside in FV. Bdph (0.1 mM) did both in CA. Bdph (0.225-0.45 mM) did the opposite to that of nitroprusside, but not forskolin, in FA. Bdph (0.45-0.9 mM) did neither in MA. Bdph (0.1-1 mM) significantly inhibited cAMP-but not cGMP-PDE activities in these four blood vessels, suggesting that Bdph more selectively inhibited the former in these tissues. The above results suggest that the higher potencies of Bdph on FV and CA than on FA and MA, may be interpreted as the reason why Bdph is useful in the treatment of angina pectoris without changing blood pressure, after Bdph administration in vivo, because the venoreturn may be reduced and the coronary flow may be increased without affecting the arterioles, such as MA, the main determinant of blood pressure.

AB - We investigated the reason why butylidenephthalide (Bdph) can have an antianginal effect without changing blood pressure in conscious rats. Isolated dog coronary artery (CA), femoral vein (FV), femoral artery (FA), and mesenteric artery (MA) were used to evaluate the relaxant effects of Bdph. Bdph concentration-dependently relaxed isolated CA, FV, FA, and MA precontracted by KCl (60 mM) and phenylephrine (phe, 5 μM) with the exception that CA was precontracted by prostaglandin F2a (PGF2a, 2μM) instead of phe. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph also concentration-dependently and non-competitively inhibited cumulative KCl (5-120 mM)- and phe (0.1 - 100 μM)-induced contractions in normal, and inhibited cumulative Ca2+-induced contractions in depolarized blood vessels. The potency order of Bdph to these blood vessels was FV > CA > FA ≥ MA. Bdph (0.02-0.04 mM) concentration-dependently and leftward-shifted the log concentration-response curves in parallel and significantly increased the pD2 value of forskolin, but not nitroprusside in FV. Bdph (0.1 mM) did both in CA. Bdph (0.225-0.45 mM) did the opposite to that of nitroprusside, but not forskolin, in FA. Bdph (0.45-0.9 mM) did neither in MA. Bdph (0.1-1 mM) significantly inhibited cAMP-but not cGMP-PDE activities in these four blood vessels, suggesting that Bdph more selectively inhibited the former in these tissues. The above results suggest that the higher potencies of Bdph on FV and CA than on FA and MA, may be interpreted as the reason why Bdph is useful in the treatment of angina pectoris without changing blood pressure, after Bdph administration in vivo, because the venoreturn may be reduced and the coronary flow may be increased without affecting the arterioles, such as MA, the main determinant of blood pressure.

KW - Butylidenephthalide

KW - Ca influx

KW - Ca release

KW - cAMP-phosphodiesterase

KW - cGMP-phosphodiesterase

KW - Dog blood vessels

KW - Ligusticum chuaxiong

KW - Umbelliferae

UR - http://www.scopus.com/inward/record.url?scp=0036862580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036862580&partnerID=8YFLogxK

U2 - 10.1055/s-2002-35671

DO - 10.1055/s-2002-35671

M3 - Article

C2 - 12451491

AN - SCOPUS:0036862580

VL - 68

SP - 1004

EP - 1009

JO - Planta Medica

JF - Planta Medica

SN - 0032-0943

IS - 11

ER -